Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
Status:
Completed
Trial end date:
2016-06-19
Target enrollment:
Participant gender:
Summary
The purpose of this study was to see if antiretroviral therapy (ART) is safe and works at
getting rid of malaria in blood and to see whether one type of ART is better than another.
This study may offer information for further research in looking at whether ART plays a role
in the prevention and treatment of malaria.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
AIDS Clinical Trials Group
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)